Virtual Reality Forest Sounds and Patient Outcomes During Chest Tube Removal

March 3, 2026 updated by: Ayça Uzun, Uskudar University

The Effect of Nature Sounds in a Virtual Reality Forest During Chest Tube Removal on Pain, Vital Signs, Comfort, and Patient Satisfaction

The aim of this study is to investigate the effects of listening to nature sounds in a virtual reality forest on pain, vital signs, comfort, and patient satisfaction during chest tube removal. This study aims to determine whether there are significant differences in pain, comfort, patient satisfaction, and vital signs between the experimental and control groups during chest tube removal. "In this study, a VR video featuring a relaxing forest environment with nature sounds will be used with a virtual reality headset. Patients will be exposed to both auditory and visual stimuli. It is anticipated that the findings of this randomized controlled experimental study will make a significant contribution to the literature and clinical

Study Overview

Detailed Description

Study Type: This research will be conducted using a pretest-posttest, randomized controlled experimental design.

Demographic Information Form This form, developed by the researcher, includes patient age, gender, education level, diagnosis, and information regarding the location of the chest tube placement.

Visual Analog Scale (Pain) Created by Price et al. (1983), this scale ranges from 0, defined as "No pain," to 10, defined as "Unbearable pain." Patients are asked to score their pain between 0 and 10, representing the intensity of the pain they experience .

Patient Satisfaction Scale A satisfaction scale was developed to assess patients' satisfaction with the chest tube removal procedure. Patients will be asked to rate their satisfaction on a scale from 0 to 10.

Vital Signs Monitoring Form This form records the patient's vital signs (systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation) before and after chest tube removal.

Comfort Scale A 0-10 scale, where one end represents "Most comfortable" and the other end represents "Most uncomfortable." The number marked by the patient indicates their level of comfort.

The researcher will identify patients in the thoracic surgery ward who are scheduled for chest tube removal and meet the sample criteria, in order to collect data for the intervention and control groups. In the ward, 28 Fr chest tubes are generally used, but 32 Fr tubes may also be applied depending on the patient's condition. The decision to remove the chest tubes is made by the responsible physician after reviewing the patient's chest X-ray following the ward visit. Chest tube removal is performed by assistant doctors in the procedure room of the ward. The assignment of participating patients to either the control or intervention group will be determined by randomization.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Kadıköy
      • Istanbul, Kadıköy, Turkey (Türkiye), 34668
        • Recruiting
        • Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Training and Research Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Ayça Uzun, MSc Student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Able to speak and understand Turkish
  • Willing to participate in the study
  • Aged 18 years or older
  • No auditory or visual impairments

Exclusion Criteria:

  • Patients with impaired orientation to time and place
  • Patients with migraine, vertigo, or dizziness
  • Illiterate patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality with Nature Sounds
Data for the intervention group will be collected using the same data collection tools and time points as the control group, with the addition of the virtual reality (VR) application. The Patient Demographic Form will be administered 15 minutes before chest tube removal. Ten minutes before the procedure, patients will complete the Visual Analog Scale (Pain) and Vital Signs Monitoring Form. Patients will be informed about the procedure. Before the attending assistant physician arrives, the VR headset and headphones will be placed on the patient, and the patient will be positioned appropriately. During the procedure, the patient will view a virtual forest environment and listen to nature sounds for 5-10 minutes. Pain will be assessed immediately after the procedure. Ten minutes after the procedure, pain, patient satisfaction, vital signs, and comfort levels will be evaluated using the corresponding scales.
During chest tube removal, the patient will wear a VR headset and headphones to view a virtual forest environment and listen to nature sounds; pain, vital signs, comfort, and patient satisfaction will be assessed during this period.
No Intervention: Control Group
For patients assigned to the control group, 15 minutes before chest tube removal, only the Patient Demographic Form will be administered, without any intervention beyond the clinical protocol. Ten minutes before the procedure, patients will complete the Visual Analog Scale (Pain) and Vital Signs Monitoring Form. Patients will be informed about the procedure. They will be placed in a semi-Fowler position and asked to raise their arms upward. Once positioned correctly, patients will be instructed to take a deep breath and hold it while the chest tube is removed. Pain will be assessed immediately after the procedure. Ten minutes after the procedure, pain, patient satisfaction, comfort, and vital signs will be evaluated using the respective scales.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level during chest tube removal
Time Frame: Pain levels will be measured 10 minutes before chest tube removal, immediately after removal, and 10 minutes after removal.
Patient pain status is determined using the Visual Analog Scale (VAS). A score of 0 indicates 'no pain,' and a score of 10 indicates 'worst possible pain.' Higher scores indicate worse outcomes
Pain levels will be measured 10 minutes before chest tube removal, immediately after removal, and 10 minutes after removal.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
vital signs- Heart Rate
Time Frame: 10 minutes before chest tube removal and 10 minutes after chest tube removal.
Heart rate is measured in beats per minute, indicating a physiological response to pain and anxiety. The normal range for adults is typically 60 to 100 bpm.
10 minutes before chest tube removal and 10 minutes after chest tube removal.
Vital signs- Respiratory Rate
Time Frame: 10 minutes before chest tube removal and 10 minutes after chest tube removal.
Respiratory rate is measured in breaths per minute to assess the physiological response to pain and increased anxiety. The normal range for adults is typically 12 to 20 breaths/minute.
10 minutes before chest tube removal and 10 minutes after chest tube removal.
Patient Satisfaction
Time Frame: The patient satisfaction scale will be administered 10 minutes after the chest tube removal.
A satisfaction scale related to the chest tube removal procedure has been created for the patients. They will be asked to rate their satisfaction between 0 and 10. On the patient satisfaction scale, a score of 0 indicates 'Not satisfied at all,' while a score of 10 indicates 'Very satisfied'.
The patient satisfaction scale will be administered 10 minutes after the chest tube removal.
Patient comfort level
Time Frame: The comfort level is asked to the patient 10 minutes after chest tube removal for both the control and VR groups
It is a scale ranging from 0 to 10 points. One end of the scale indicates 'maximum comfort,' while the other end indicates 'maximum discomfort.' The number marked reflects the level of comfort. On the Comfort Scale, a score of 0 indicates the 'most comfortable state,' while a score of 10 indicates the 'most uncomfortable state.' Higher scores indicate worse outcomes (discomfort)
The comfort level is asked to the patient 10 minutes after chest tube removal for both the control and VR groups
Vital Signs- Peripheral Oxygen Saturation (SpO₂)
Time Frame: 10 minutes before chest tube removal and 10 minutes after chest tube removal.
Peripheral Oxygen Saturation is measured via pulse oximetry, reflecting potential changes in respiratory function due to pain and anxiety. Normal saturation levels are generally considered 95% and above.
10 minutes before chest tube removal and 10 minutes after chest tube removal.
Vital Signs- Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
Time Frame: 10 minutes before chest tube removal and 10 minutes after chest tube removal.
Systolic Blood Pressure is measured in millimeters of mercury (mmHg), reflecting the effects of pain and stress on the cardiovascular system. Diastolic Blood Pressure is measured in millimeters of mercury (mmHg), reflecting the effects of pain and stress on the cardiovascular system. Normal systolic pressure is generally considered less than 120 mmHg. Normal diastolic pressure is generally considered less than 80 mmHg.
10 minutes before chest tube removal and 10 minutes after chest tube removal.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

November 29, 2025

First Submitted That Met QC Criteria

March 3, 2026

First Posted (Actual)

March 9, 2026

Study Record Updates

Last Update Posted (Actual)

March 9, 2026

Last Update Submitted That Met QC Criteria

March 3, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Virtual Reality

Clinical Trials on Virtual Reality with Nature Sounds

Subscribe